nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—PDGFRA—refractive error	0.82	1	CbGaD
Nilotinib—Ponatinib—PDGFRA—refractive error	0.00502	0.619	CrCbGaD
Nilotinib—Imatinib—PDGFRA—refractive error	0.00309	0.381	CrCbGaD
Nilotinib—EPHB2—retina—refractive error	0.00185	0.0978	CbGeAlD
Nilotinib—EPHA8—eye—refractive error	0.00179	0.0946	CbGeAlD
Nilotinib—CDC42BPB—eye—refractive error	0.00165	0.0872	CbGeAlD
Nilotinib—CDC42BPB—retina—refractive error	0.00164	0.0864	CbGeAlD
Nilotinib—EPHA3—eye—refractive error	0.00157	0.0827	CbGeAlD
Nilotinib—EPHA3—retina—refractive error	0.00155	0.0819	CbGeAlD
Nilotinib—MAPK8—eye—refractive error	0.00149	0.0789	CbGeAlD
Nilotinib—MAPK8—retina—refractive error	0.00148	0.0782	CbGeAlD
Nilotinib—MAP4K1—retina—refractive error	0.00135	0.071	CbGeAlD
Nilotinib—CA12—eye—refractive error	0.00072	0.038	CbGeAlD
Nilotinib—CSF1R—eye—refractive error	0.000687	0.0362	CbGeAlD
Nilotinib—PDGFRB—eye—refractive error	0.000609	0.0321	CbGeAlD
Nilotinib—CA1—eye—refractive error	0.00057	0.0301	CbGeAlD
Nilotinib—ABL1—eye—refractive error	0.000543	0.0287	CbGeAlD
Nilotinib—ABL1—retina—refractive error	0.000538	0.0284	CbGeAlD
Nilotinib—CA2—eye—refractive error	0.00037	0.0195	CbGeAlD
Nilotinib—CA2—retina—refractive error	0.000366	0.0193	CbGeAlD
Nilotinib—ABCB1—retina—refractive error	0.000167	0.00883	CbGeAlD
Nilotinib—MAPK14—Signaling Pathways—AXL—refractive error	4.48e-05	0.000293	CbGpPWpGaD
Nilotinib—LCK—Disease—RNF111—refractive error	4.42e-05	0.00029	CbGpPWpGaD
Nilotinib—MAPK14—Insulin Signaling—PTEN—refractive error	4.42e-05	0.000289	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—VANGL2—refractive error	4.42e-05	0.000289	CbGpPWpGaD
Nilotinib—PDGFRB—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	4.39e-05	0.000288	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by FGFR in disease—PTEN—refractive error	4.39e-05	0.000288	CbGpPWpGaD
Nilotinib—PDGFRB—DAP12 interactions—PTEN—refractive error	4.39e-05	0.000288	CbGpPWpGaD
Nilotinib—MAPK14—EGF/EGFR Signaling Pathway—PTEN—refractive error	4.37e-05	0.000286	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by EGFR—PTEN—refractive error	4.35e-05	0.000285	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—VIPR2—refractive error	4.35e-05	0.000285	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—VANGL2—refractive error	4.32e-05	0.000283	CbGpPWpGaD
Nilotinib—MAPK11—Innate Immune System—PDGFRA—refractive error	4.32e-05	0.000283	CbGpPWpGaD
Nilotinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	4.32e-05	0.000283	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by EGFR in Cancer—PTEN—refractive error	4.31e-05	0.000282	CbGpPWpGaD
Nilotinib—LYN—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	4.3e-05	0.000281	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by PDGF—PTEN—refractive error	4.29e-05	0.000281	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—RPS27—refractive error	4.29e-05	0.000281	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CER1—refractive error	4.28e-05	0.000281	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TJP2—refractive error	4.28e-05	0.000281	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—RNF111—refractive error	4.28e-05	0.000281	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—PML—refractive error	4.23e-05	0.000277	CbGpPWpGaD
Nilotinib—LCK—Signaling by SCF-KIT—PTEN—refractive error	4.23e-05	0.000277	CbGpPWpGaD
Nilotinib—PDGFRB—Focal Adhesion—PTEN—refractive error	4.15e-05	0.000272	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—EBP—refractive error	4.12e-05	0.00027	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—WNT10A—refractive error	4.11e-05	0.000269	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—VANGL2—refractive error	4.1e-05	0.000268	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—RDH5—refractive error	4.09e-05	0.000268	CbGpPWpGaD
Nilotinib—LCK—Immune System—CTSC—refractive error	4.07e-05	0.000267	CbGpPWpGaD
Nilotinib—PDGFRB—B Cell Activation—PTEN—refractive error	4.06e-05	0.000266	CbGpPWpGaD
Nilotinib—LCK—Downstream signaling of activated FGFR—PTEN—refractive error	4.04e-05	0.000265	CbGpPWpGaD
Nilotinib—ABL1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	4.03e-05	0.000264	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—WNT10A—refractive error	4.02e-05	0.000263	CbGpPWpGaD
Nilotinib—LCK—Signaling by ERBB4—PTEN—refractive error	3.98e-05	0.000261	CbGpPWpGaD
Nilotinib—LYN—B Cell Activation—PTEN—refractive error	3.98e-05	0.000261	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—PDGFRA—refractive error	3.9e-05	0.000255	CbGpPWpGaD
Nilotinib—MAPK11—Signaling by NGF—PTEN—refractive error	3.89e-05	0.000255	CbGpPWpGaD
Nilotinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	3.89e-05	0.000255	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—AXL—refractive error	3.88e-05	0.000254	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—RPS27—refractive error	3.87e-05	0.000253	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—RPS27—refractive error	3.86e-05	0.000253	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TJP2—refractive error	3.86e-05	0.000253	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CER1—refractive error	3.86e-05	0.000253	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—RNF111—refractive error	3.86e-05	0.000253	CbGpPWpGaD
Nilotinib—BRAF—Signaling by NGF—PTEN—refractive error	3.85e-05	0.000252	CbGpPWpGaD
Nilotinib—LCK—Disease—LUM—refractive error	3.84e-05	0.000251	CbGpPWpGaD
Nilotinib—MAPK14—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	3.83e-05	0.000251	CbGpPWpGaD
Nilotinib—KIT—Immune System—PML—refractive error	3.81e-05	0.00025	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—WNT10A—refractive error	3.81e-05	0.00025	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—COL9A1—refractive error	3.8e-05	0.000249	CbGpPWpGaD
Nilotinib—LCK—Downstream signal transduction—PTEN—refractive error	3.8e-05	0.000249	CbGpPWpGaD
Nilotinib—LCK—Signaling by FGFR—PTEN—refractive error	3.78e-05	0.000248	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CER1—refractive error	3.78e-05	0.000247	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—RNF111—refractive error	3.78e-05	0.000247	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TJP2—refractive error	3.78e-05	0.000247	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—COL9A1—refractive error	3.77e-05	0.000247	CbGpPWpGaD
Nilotinib—LCK—Signaling by ERBB2—PTEN—refractive error	3.76e-05	0.000246	CbGpPWpGaD
Nilotinib—LCK—DAP12 signaling—PTEN—refractive error	3.75e-05	0.000245	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—PDGFRA—refractive error	3.74e-05	0.000245	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—DSE—refractive error	3.69e-05	0.000242	CbGpPWpGaD
Nilotinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—PTEN—refractive error	3.69e-05	0.000242	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—LUM—refractive error	3.67e-05	0.00024	CbGpPWpGaD
Nilotinib—MAPK14—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	3.61e-05	0.000236	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—PML—refractive error	3.61e-05	0.000236	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—EBP—refractive error	3.59e-05	0.000235	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CER1—refractive error	3.58e-05	0.000235	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—RNF111—refractive error	3.58e-05	0.000235	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TJP2—refractive error	3.58e-05	0.000235	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—VANGL2—refractive error	3.54e-05	0.000232	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CACNA1D—refractive error	3.53e-05	0.000231	CbGpPWpGaD
Nilotinib—LCK—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	3.52e-05	0.000231	CbGpPWpGaD
Nilotinib—LCK—DAP12 interactions—PTEN—refractive error	3.52e-05	0.000231	CbGpPWpGaD
Nilotinib—LCK—Signaling by FGFR in disease—PTEN—refractive error	3.52e-05	0.000231	CbGpPWpGaD
Nilotinib—KIT—Signaling by NGF—PTEN—refractive error	3.51e-05	0.00023	CbGpPWpGaD
Nilotinib—LCK—Signaling by EGFR—PTEN—refractive error	3.49e-05	0.000229	CbGpPWpGaD
Nilotinib—HCK—Immune System—PDGFRA—refractive error	3.49e-05	0.000228	CbGpPWpGaD
Nilotinib—LCK—Signaling by EGFR in Cancer—PTEN—refractive error	3.46e-05	0.000227	CbGpPWpGaD
Nilotinib—LCK—Signaling by PDGF—PTEN—refractive error	3.45e-05	0.000226	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—COL9A1—refractive error	3.43e-05	0.000225	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—EBP—refractive error	3.39e-05	0.000222	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	3.38e-05	0.000221	CbGpPWpGaD
Nilotinib—CA3—Metabolism—PTEN—refractive error	3.38e-05	0.000221	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—EBP—refractive error	3.36e-05	0.00022	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—PDGFRA—refractive error	3.32e-05	0.000218	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling by NGF—PTEN—refractive error	3.32e-05	0.000217	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—WNT10A—refractive error	3.29e-05	0.000216	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PCCA—refractive error	3.29e-05	0.000215	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PLA2G16—refractive error	3.29e-05	0.000215	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—BMP2—refractive error	3.27e-05	0.000214	CbGpPWpGaD
Nilotinib—LCK—B Cell Activation—PTEN—refractive error	3.26e-05	0.000214	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—PDGFRA—refractive error	3.25e-05	0.000213	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—PML—refractive error	3.25e-05	0.000213	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—COL9A1—refractive error	3.25e-05	0.000213	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—PDGFRA—refractive error	3.24e-05	0.000212	CbGpPWpGaD
Nilotinib—HCK—Disease—PDGFRA—refractive error	3.22e-05	0.000211	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—PDGFRA—refractive error	3.19e-05	0.000209	CbGpPWpGaD
Nilotinib—LYN—Immune System—PML—refractive error	3.18e-05	0.000208	CbGpPWpGaD
Nilotinib—ABL1—Immune System—PML—refractive error	3.17e-05	0.000207	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—PDGFRA—refractive error	3.16e-05	0.000207	CbGpPWpGaD
Nilotinib—BLK—Immune System—PDGFRA—refractive error	3.16e-05	0.000207	CbGpPWpGaD
Nilotinib—FGR—Immune System—PDGFRA—refractive error	3.15e-05	0.000206	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—DSE—refractive error	3.13e-05	0.000205	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—PDGFRA—refractive error	3.12e-05	0.000205	CbGpPWpGaD
Nilotinib—LCK—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	3.12e-05	0.000204	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CYP26A1—refractive error	3.12e-05	0.000204	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—LUM—refractive error	3.11e-05	0.000204	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—BMP2—refractive error	3.11e-05	0.000204	CbGpPWpGaD
Nilotinib—LCK—Disease—RPS27—refractive error	3.1e-05	0.000203	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—RNF111—refractive error	3.1e-05	0.000203	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CER1—refractive error	3.1e-05	0.000203	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TJP2—refractive error	3.1e-05	0.000203	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—PDGFRA—refractive error	3.08e-05	0.000202	CbGpPWpGaD
Nilotinib—HCK—Innate Immune System—PTEN—refractive error	3.07e-05	0.000201	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—PML—refractive error	3.02e-05	0.000198	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CACNA1D—refractive error	3e-05	0.000196	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by NGF—PTEN—refractive error	2.99e-05	0.000196	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—COL9A1—refractive error	2.93e-05	0.000192	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—COL9A1—refractive error	2.86e-05	0.000188	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—TUBB3—refractive error	2.84e-05	0.000186	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PLA2G16—refractive error	2.79e-05	0.000182	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PCCA—refractive error	2.79e-05	0.000182	CbGpPWpGaD
Nilotinib—MAPK8—Innate Immune System—PTEN—refractive error	2.78e-05	0.000182	CbGpPWpGaD
Nilotinib—MAPK14—Signaling by NGF—PTEN—refractive error	2.78e-05	0.000182	CbGpPWpGaD
Nilotinib—FGR—Innate Immune System—PTEN—refractive error	2.78e-05	0.000182	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—DSE—refractive error	2.72e-05	0.000178	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—COL9A1—refractive error	2.72e-05	0.000178	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—PTEN—refractive error	2.67e-05	0.000175	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—PDGFRA—refractive error	2.67e-05	0.000175	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CYP26A1—refractive error	2.65e-05	0.000173	CbGpPWpGaD
Nilotinib—LCK—Immune System—PML—refractive error	2.61e-05	0.000171	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—BMP2—refractive error	2.61e-05	0.000171	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—BMP2—refractive error	2.58e-05	0.000169	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—DSE—refractive error	2.57e-05	0.000168	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—PDGFRA—refractive error	2.56e-05	0.000168	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—DSE—refractive error	2.54e-05	0.000167	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—PDGFRA—refractive error	2.52e-05	0.000165	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PCCA—refractive error	2.43e-05	0.000159	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PLA2G16—refractive error	2.43e-05	0.000159	CbGpPWpGaD
Nilotinib—LCK—Signaling by NGF—PTEN—refractive error	2.4e-05	0.000157	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—BMP2—refractive error	2.35e-05	0.000154	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—COL9A1—refractive error	2.35e-05	0.000154	CbGpPWpGaD
Nilotinib—BRAF—Disease—PDGFRA—refractive error	2.3e-05	0.000151	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PLA2G16—refractive error	2.29e-05	0.00015	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PCCA—refractive error	2.29e-05	0.00015	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—LUM—refractive error	2.28e-05	0.000149	CbGpPWpGaD
Nilotinib—KIT—Immune System—PDGFRA—refractive error	2.27e-05	0.000149	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PCCA—refractive error	2.27e-05	0.000148	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PLA2G16—refractive error	2.27e-05	0.000148	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—BMP2—refractive error	2.23e-05	0.000146	CbGpPWpGaD
Nilotinib—MAPK11—Innate Immune System—PTEN—refractive error	2.22e-05	0.000145	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—EBP—refractive error	2.21e-05	0.000145	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CACNA1D—refractive error	2.2e-05	0.000144	CbGpPWpGaD
Nilotinib—CA14—Metabolism—PTEN—refractive error	2.18e-05	0.000142	CbGpPWpGaD
Nilotinib—CA6—Metabolism—PTEN—refractive error	2.12e-05	0.000139	CbGpPWpGaD
Nilotinib—KIT—Disease—PDGFRA—refractive error	2.1e-05	0.000137	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—PDGFRA—refractive error	2.04e-05	0.000134	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—BMP2—refractive error	2.01e-05	0.000131	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—PTEN—refractive error	2e-05	0.000131	CbGpPWpGaD
Nilotinib—CA7—Metabolism—PTEN—refractive error	1.98e-05	0.00013	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—BMP2—refractive error	1.96e-05	0.000129	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—PDGFRA—refractive error	1.94e-05	0.000127	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CYP26A1—refractive error	1.94e-05	0.000127	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—PDGFRA—refractive error	1.94e-05	0.000127	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—LUM—refractive error	1.93e-05	0.000126	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—PTEN—refractive error	1.92e-05	0.000126	CbGpPWpGaD
Nilotinib—LYN—Immune System—PDGFRA—refractive error	1.89e-05	0.000124	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—PTEN—refractive error	1.89e-05	0.000124	CbGpPWpGaD
Nilotinib—ABL1—Immune System—PDGFRA—refractive error	1.89e-05	0.000124	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—BMP2—refractive error	1.86e-05	0.000122	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CACNA1D—refractive error	1.86e-05	0.000122	CbGpPWpGaD
Nilotinib—CA12—Metabolism—PTEN—refractive error	1.83e-05	0.00012	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—PTEN—refractive error	1.82e-05	0.000119	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—PDGFRA—refractive error	1.8e-05	0.000118	CbGpPWpGaD
Nilotinib—HCK—Immune System—PTEN—refractive error	1.79e-05	0.000117	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—PDGFRA—refractive error	1.79e-05	0.000117	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	1.74e-05	0.000114	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—PTEN—refractive error	1.71e-05	0.000112	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—LUM—refractive error	1.68e-05	0.00011	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—DSE—refractive error	1.68e-05	0.00011	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—PTEN—refractive error	1.67e-05	0.000109	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—PTEN—refractive error	1.66e-05	0.000109	CbGpPWpGaD
Nilotinib—HCK—Disease—PTEN—refractive error	1.65e-05	0.000108	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CYP26A1—refractive error	1.64e-05	0.000108	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—PTEN—refractive error	1.64e-05	0.000107	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—PDGFRA—refractive error	1.63e-05	0.000107	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—PTEN—refractive error	1.62e-05	0.000106	CbGpPWpGaD
Nilotinib—BLK—Immune System—PTEN—refractive error	1.62e-05	0.000106	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CACNA1D—refractive error	1.62e-05	0.000106	CbGpPWpGaD
Nilotinib—FGR—Immune System—PTEN—refractive error	1.62e-05	0.000106	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—PDGFRA—refractive error	1.61e-05	0.000106	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—BMP2—refractive error	1.61e-05	0.000105	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—PTEN—refractive error	1.6e-05	0.000105	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—LUM—refractive error	1.59e-05	0.000104	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—PTEN—refractive error	1.58e-05	0.000104	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—LUM—refractive error	1.57e-05	0.000103	CbGpPWpGaD
Nilotinib—LCK—Immune System—PDGFRA—refractive error	1.55e-05	0.000102	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CACNA1D—refractive error	1.53e-05	9.99e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CACNA1D—refractive error	1.51e-05	9.91e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PCCA—refractive error	1.5e-05	9.79e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PLA2G16—refractive error	1.5e-05	9.79e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—PDGFRA—refractive error	1.47e-05	9.61e-05	CbGpPWpGaD
Nilotinib—CA4—Metabolism—PTEN—refractive error	1.46e-05	9.58e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—PDGFRA—refractive error	1.43e-05	9.39e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CYP26A1—refractive error	1.43e-05	9.37e-05	CbGpPWpGaD
Nilotinib—CA2—Metabolism—PTEN—refractive error	1.4e-05	9.18e-05	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—PTEN—refractive error	1.37e-05	8.96e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CYP26A1—refractive error	1.35e-05	8.83e-05	CbGpPWpGaD
Nilotinib—CA1—Metabolism—PTEN—refractive error	1.34e-05	8.8e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CYP26A1—refractive error	1.34e-05	8.75e-05	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—PTEN—refractive error	1.31e-05	8.61e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—PTEN—refractive error	1.29e-05	8.46e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—PDGFRA—refractive error	1.25e-05	8.19e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—PDGFRA—refractive error	1.23e-05	8.02e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—PTEN—refractive error	1.18e-05	7.74e-05	CbGpPWpGaD
Nilotinib—CA9—Metabolism—PTEN—refractive error	1.18e-05	7.74e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—PTEN—refractive error	1.17e-05	7.63e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—PDGFRA—refractive error	1.16e-05	7.6e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—PTEN—refractive error	1.1e-05	7.22e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—PTEN—refractive error	1.08e-05	7.04e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—PTEN—refractive error	1.05e-05	6.87e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—LUM—refractive error	1.04e-05	6.79e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—PTEN—refractive error	1.02e-05	6.67e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PDGFRA—refractive error	1e-05	6.58e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CACNA1D—refractive error	9.98e-06	6.53e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—PTEN—refractive error	9.97e-06	6.53e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—PTEN—refractive error	9.94e-06	6.51e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—PTEN—refractive error	9.73e-06	6.37e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—PTEN—refractive error	9.68e-06	6.34e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—PTEN—refractive error	9.22e-06	6.04e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—PTEN—refractive error	9.17e-06	6.01e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP26A1—refractive error	8.81e-06	5.77e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—PTEN—refractive error	8.35e-06	5.47e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—refractive error	8.32e-06	5.45e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—PTEN—refractive error	8.28e-06	5.42e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—PTEN—refractive error	7.97e-06	5.22e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—PTEN—refractive error	7.53e-06	4.93e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—PTEN—refractive error	7.36e-06	4.82e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—PTEN—refractive error	7.13e-06	4.67e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—PTEN—refractive error	7.04e-06	4.61e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—refractive error	6.77e-06	4.44e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—PTEN—refractive error	6.42e-06	4.21e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—PTEN—refractive error	6.29e-06	4.12e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PTEN—refractive error	5.97e-06	3.91e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—PTEN—refractive error	5.96e-06	3.9e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PTEN—refractive error	5.16e-06	3.38e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PTEN—refractive error	4.38e-06	2.87e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PTEN—refractive error	3.71e-06	2.43e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PTEN—refractive error	3.23e-06	2.11e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PTEN—refractive error	3.04e-06	1.99e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PTEN—refractive error	3.02e-06	1.98e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PTEN—refractive error	1.99e-06	1.3e-05	CbGpPWpGaD
